MGCD-265 analog T6351
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
MGCD-265-analog (structurally related to MGCD-265) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
CAS nr:
875337-44-3
Purity:
98%
Molecular Weight:
517,6
SMILES:
Cn1cc(nc1)c1cc2nccc(c2s1)Oc1c(cc(cc1)NC(=S)NC(=O)Cc1ccccc1)F
Formula:
C26H20FN5O2S2
Pathway:
Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Apoptosis
Target:
c-Met/HGFR,VEGFR,VEGFR,Apoptosis
